Diagnosis and risk stratification of fungal infections
A technology for risk stratification and in vitro diagnosis, applied in the field of diagnostic assays and kits, which can solve problems such as undisclosed pro-adrenomedullin, undisclosed diagnosis, etc.
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Image
Examples
Embodiment 1
[0113] Research design. The observational clinical study was approved by the local ethics committee (Ethics Committee of Heidelberg Medical School, Trial Code S-097 / 2013 / German Clinical Trials Register: DRKS00005463) and was conducted in Germany between November 2013 and January 2015 Performed in the Surgical Intensive Care Unit of the University Hospital Heidelberg. All study patients or their legal representatives signed the informed consent. In this study, a total of 50 patients with sepsis were recruited according to the criteria of Surviving Sepsis Campaign: International Guidelines for Management of Severe Sepsis and Septic Shock 2012. Patients with hemorrhagic shock (Dellinger RP, Levy MM, Rhodes A, etc., (2013) Surviving sepsis campaign: international guidelines for management of severe sepsis and septicshock: 2012. Crit Care Med41: 580-637). Treatment of patients with septic shock includes early goal-directed therapy (Romani L (2004) Immunity to fungal infections. "...
PUM
Abstract
Description
Claims
Application Information
- R&D Engineer
- R&D Manager
- IP Professional
- Industry Leading Data Capabilities
- Powerful AI technology
- Patent DNA Extraction
Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.
© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com